Exploring the link between glycoxidation and arterial health in at-risk individuals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between glycoxidation, arterial biomechanics, and target organ damage in individuals with moderate to high cardiovascular risk. It aims to understand how glycation and oxidative stress affect arterial health and contribute to vascular aging. The study will collect demographic, clinical, and anthropometric data from non-smoking participants over 18 years old, who do not have diabetes or established cardiovascular disease. By analyzing these factors, researchers hope to uncover insights into the mechanisms of cardiovascular risk and potential early indicators of target organ damage.

Why it matters

Who can join: the full rules

INCLUSION CRITERIA

* Age 18 years or older.
* Written informed consent to participate in the registry.
* Undergoing cardiovascular risk or hypertension assessment in a primary-prevention setting.
* At least one of the following cardiovascular risk conditions:

  * Confirmed hypertension requiring specialist cardiovascular assessment.
  * A SCORE2 estimated 10-year cardiovascular risk of 2% or higher in participants aged 40 to 69 years, when SCORE2 is applicable.
  * A SCORE2-OP estimated 10-year cardiovascular risk of 2% or higher in participants aged 70 to 89 years, when SCORE2-OP is applicable.
  * Type 2 diabetes with at least moderate cardiovascular risk according to SCORE2-Diabetes in participants within its validated age range, or according to guideline-defined clinical risk criteria when SCORE2-Diabetes is not applicable.
  * Chronic kidney disease confirmed for at least 3 months, defined by an estimated glomerular filtration rate below 60 mL/min/1.73 m², a urinary albumin-to-creatinine ratio of 30 mg/g or higher, or another persistent marker of kidney damage.
  * Hypertension-mediated target-organ damage or subclinical atherosclerotic vascular disease documented by clinical, laboratory, imaging, or functional assessment.
  * Confirmed or probable familial hypercholesterolemia.
  * For participants aged 18 to 39 years or older than 89 years, a documented major cardiovascular risk condition, such as hypertension, type 2 diabetes, chronic kidney disease, familial hypercholesterolemia, or target-organ damage.

EXCLUSION CRITERIA

* Inability or unwillingness to provide written informed consent.
* Established clinical cardiovascular disease requiring secondary-prevention management, including previous myocardial infarction, acute coronary syndrome, stroke, transient ischemic attack, coronary or peripheral revascularization, symptomatic peripheral artery disease, or other established symptomatic cardiovascular disease.
* Acute or clinically unstable illness that prevents completion of the baseline registry assessment.
* A medical, technical, cognitive, or logistical condition that prevents completion of the minimum required registry procedures.

Where it's running

• Complejo Hospitalario Universitario de Santiago de Compostela
  Santiago de Compostela, A Coruña, Spain Recruiting

Study contacts

• Study coordinator: Nestor Vazquez-Agra, PhD
• Email: nestor.vazquez.agra@sergas.es
• Phone: 0034981951256

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clazakizumab for adults with high hsCRP at risk for a heart event

  This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.

  Recruiting at 32 sites Phase 2 Eli Lilly and Company · Huntsville, Alabama and 45 other locations · NCT07783802

• Investigating body fat distribution and its impact on metabolic diseases in Japanese adults

  This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.

  Recruiting Osaka Metropolitan University · Sakai, Osaka · NCT06694012

• Assessing blood pressure treatment effects on arterial stiffness in older veterans

  This study is testing whether different blood pressure treatment goals can help reduce arterial stiffness in older veterans with high blood pressure.

  Recruiting VA Office of Research and Development · Birmingham, Alabama and 2 other locations · NCT06495710

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

• Micro-doses of physical activity for improving blood vessel health in COPD patients

  This study tests if short walks can help improve blood vessel health in people with COPD who sit for long periods.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT05553223

• IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension

  This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.

  Recruiting at 8 sites Bahir Dar University · Ādēt and 7 other locations · NCT07894068

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.